Iopamidol

Common Uses

Iopamidol is an iodine-based contrast medium. When injected into the body, it helps create a clearer picture of internal organs, blood vessels, and other tissues during diagnostic procedures. It is primarily used for the following:

• Angiography: To visualize the heart, arteries, and veins to identify blockages, narrowing, or other vascular conditions.
• Computed Tomography (CT): To enhance images of the brain and body, helping to identify tumors, infections, or injuries.
• Urography: To examine the structure and function of the kidneys, bladder, and urinary tract.
• Myelography: To view the spinal cord, nerve roots, and the space around them.
• Arthrography: To evaluate the condition of joints, such as the shoulder or knee.

By providing better contrast between different types of tissue, iopamidol assists doctors in making more accurate diagnoses of various medical conditions.

Mechanism of Action

Iopamidol is classified as a radiopaque contrast medium. It works by using iodine atoms to block or absorb X-ray radiation as it passes through the body.

During a diagnostic procedure, iopamidol is injected into a vein, artery, or the space around the spinal cord. As the substance moves through the body, it fills the targeted area. Because iodine is dense, it prevents X-rays from reaching the film or digital sensor in those specific spots. This results in the targeted area appearing bright white on the image, providing a sharp contrast against the darker background of surrounding tissues.

This contrast allows doctors to more easily identify:

• Blockages or narrowing in the blood vessels.
• The size and shape of specific organs.
• Abnormalities in the brain or spinal cord.

Iopamidol is water-soluble, which allows it to mix easily with body fluids. After the imaging is complete, the drug is typically filtered out of the bloodstream by the kidneys and excreted in the urine.

Common Side Effects

Many people experience mild side effects during or shortly after receiving an iopamidol injection. These may include:

• Nausea or vomiting
• Headache or dizziness
• A metallic taste in the mouth
• Flushing or a sudden feeling of warmth
• Mild skin rash or itching
• Pain, burning, or redness at the injection site

Serious Side Effects

While less common, some side effects can be severe. Seek medical help immediately if you experience:

• Signs of a severe allergic reaction, such as hives, swelling of the face, lips, or throat, and difficulty breathing
• Chest pain, fast or irregular heartbeat, or shortness of breath
• Sudden weakness, confusion, or problems with speech, balance, or vision
• Seizures
• Signs of kidney problems, including little or no urination or swelling in the feet and ankles
• Severe skin reactions, such as blistering, peeling, or a red skin rash that spreads
• Extreme drowsiness or lightheadedness

Severe Allergic Reactions

Serious and potentially life-threatening hypersensitivity reactions, including anaphylaxis, can occur following the administration of iopamidol. These reactions may involve cardiovascular collapse, cardiac arrest, or severe respiratory distress. Patients with a history of asthma, hay fever, or previous reactions to iodine-based contrast media are at an increased risk.

Renal Complications

Iodinated contrast agents can cause acute kidney injury or contrast-induced nephropathy. The risk is higher for individuals with:

• Pre-existing kidney disease
• Diabetes mellitus
• Dehydration
• Congestive heart failure
• Advanced age

Adequate hydration before and after the procedure is often recommended to help reduce the risk of kidney damage.

Severe Skin Reactions

Severe cutaneous adverse reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. These reactions can be delayed, appearing several days after the injection.

Thyroid and Endocrine Concerns

Iopamidol may trigger a thyroid storm in patients with hyperthyroidism. In pediatric patients, particularly neonates and infants, iodinated contrast can cause temporary hypothyroidism. Monitoring of thyroid function may be necessary for young children after exposure.

Additional Risks

• Pheochromocytoma: Administration may cause a sudden, severe increase in blood pressure (hypertensive crisis) in patients with this type of adrenal gland tumor.
• Sickle Cell Disease: Contrast media may promote the sickling of red blood cells in patients with sickle cell disease or trait.
• Extravasation: If the injection leaks into the surrounding tissue rather than staying in the vein, it can cause local tissue irritation or damage.

Pregnancy

The safety of iopamidol during pregnancy has not been fully established. There are no adequate and well-controlled studies in pregnant women, and animal reproduction studies have not been conducted to determine if the drug affects the fetus or reproductive capacity. Because it is unknown whether iopamidol can cause fetal harm, it should be administered to a pregnant woman only if a healthcare provider determines the procedure is clearly needed.

Breastfeeding

It is not known whether iopamidol is excreted in human breast milk. Because many medications are passed through milk, healthcare providers typically advise caution when administering this injection to someone who is nursing. Patients should discuss the potential risks and benefits with their doctor before undergoing a diagnostic procedure that involves iopamidol.

Available Forms

Iopamidol is provided as a clear, colorless to pale yellow aqueous solution for injection or infusion. It is available in several packaging formats designed for clinical use:

• Single-dose vials and bottles
• Pre-filled syringes
• Pharmacy bulk packages
• Imaging bulk packages

Strengths

The concentration of iopamidol is measured by the amount of iodine per milliliter (mgI/mL). Common strengths include:

• 200 mgI/mL
• 250 mgI/mL
• 300 mgI/mL
• 370 mgI/mL

The choice of concentration and the total volume administered depend on the specific diagnostic procedure, such as computed tomography (CT) scans, angiography, or myelography.

FDA Approval and Indications

Iopamidol is approved by the U.S. Food and Drug Administration (FDA) as a nonionic, water-soluble contrast medium. It is indicated for use in various radiologic procedures to help visualize internal structures, including:

• Angiography (imaging of blood vessels)
• Computed tomography (CT) scans of the head and body
• Excretory urography
• Imaging of the spinal cord (myelography)

Safety Communications

The FDA monitors potential safety signals related to the use of iodinated contrast media like iopamidol. In 2015, the agency identified a potential risk of thyroid dysfunction, specifically hypothyroidism, in infants and children following the administration of these agents. The FDA continues to evaluate safety data to determine if additional labeling changes are necessary for pediatric populations.

Regulatory Requirements

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) programs required for iopamidol. It is classified as a prescription-only medication and must be administered by healthcare professionals in a clinical or hospital setting.

Pregnancy and Iopamidol

The safety of iopamidol for use during pregnancy has not been established through well-controlled studies in humans. Because it is unknown whether this contrast agent can cause fetal harm or affect reproductive capacity, it is generally reserved for situations where the diagnostic procedure is clearly needed.

Considerations for pregnant patients include:

• Animal Research: Studies in animals using doses significantly higher than the standard human dose did not show evidence of impaired fertility or harm to the fetus. However, results from animal studies do not always predict human response.
• Clinical Necessity: Healthcare providers will evaluate whether the information gained from the imaging procedure outweighs any potential risks to the pregnancy.
• Thyroid Function: Exposure to iodinated contrast media in the womb may occasionally affect the thyroid function of the newborn. In some cases, healthcare providers may recommend monitoring the infant's thyroid levels after birth.

It is essential to inform your doctor, radiologist, or imaging technician if you are pregnant, suspect you might be pregnant, or are planning to become pregnant before receiving an injection of iopamidol.